Groups urge FDA to halt launch of Zohydro pain drug

A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month. The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. A single capsule could be fatal if swallowed by a child," they wrote in a petition to FDA Commissioner Margaret Hamburg, dated Wednesday. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.



via Health News Headlines - Yahoo News http://ift.tt/1fM8EdO